Mosunetuzumab and Polatuzumab Vedotin Demonstrates Preliminary Efficacy in Elderly Unfit/Frail Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

被引：11

作者：

Olszewski, Adam J. ^{[1
]}

Eradat, Herbert ^{[2
]}

Avigdor, Abraham ^{[3
,4
]}

Horowitz, Netanel A. ^{[5
]}

Babu, Sunil ^{[6
]}

Levi, Itai ^{[7
]}

McKinney, Matthew ^{[8
]}

Lee, Seung Tae ^{[9
]}

Bergua Burgues, Juan Miguel ^{[10
]}

Rodriguez Izquierdo, Antonia ^{[11
]}

Bastos-Oreiro, Mariana ^{[12
]}

Ganzel, Chezi ^{[13
,14
]}

Kim, Tae Min ^{[15
]}

Jeon, Youngwoo ^{[16
]}

Taszner, Michal ^{[17
]}

Narkhede, Mayur ^{[18
]}

Kim, Won Seog ^{[19
]}

Shin, Ho-Jin ^{[20
]}

Lavie, David ^{[21
]}

Woszczyk, Dariusz ^{[22
]}

Dunshee, Diana ^{[23
]}

Kapp, Amy V. ^{[23
]}

Zhou, Mingzhu ^{[24
]}

Batlevi, Connie Lee ^{[23
]}

Ead, Wahib ^{[23
]}

Sellam, Gila ^{[25
]}

Jurczak, Wojciech ^{[26
]}

机构：

[1] Brown Univ, Providence, RI USA

[2] Univ Calif Los Angeles, Los Angeles, CA USA

[3] Sheba Med Ctr, Ramat Gan, Israel

[4] Tel Aviv Univ, Sch Med, Tel Aviv, Israel

[5] Technion, Rambam Hlth Care Campus, Haifa, Israel

[6] Ft Wayne Med Oncol & Hematol, Ft Wayne, IN USA

[7] Soroka Univ Med Ctr, Beer Sheva, Israel

[8] Duke Canc Inst, Durham, NC USA

[9] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD USA

[10] San Pedro Alcantara Hosp, Hematol & Hemotherapy Serv, Caceres, Spain

[11] Univ Hosp October, Madrid, Spain

[12] Hosp Gen Univ Gregorio Maranon, Madrid, Spain

[13] Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel

[14] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel

[15] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[16] Yeouido St Marys Hosp, Lymphoma & Cell Therapy Res Ctr, Seoul, South Korea

[17] Med Univ Gdansk, Univ Clin Ctr, Dept Hematol & Transplantol, Gdansk, Poland

[18] Univ Alabama Birmingham, Birmingham, AL USA

[19] Sungkyunkwan Univ, Sch Med, Seoul, South Korea

[20] Pusan Natl Univ, Pusan Natl Univ Hosp, Biochem Res Inst,Sch Med, Dept Internal Med,Div Hematol Oncol, Busan, South Korea

[21] Hadassah Med Ctr, Jerusalem, Israel

[22] Univ Opole, Prov Hosp, Opole, Poland

[23] Genentech Inc, San Francisco, CA USA

[24] F Hoffmann La Roche Ltd, Shanghai, Peoples R China

[25] F Hoffmann La Roche Ltd, Basel, Switzerland

[26] Maria Sklodowska Curie Natl Res Inst Oncol, Krakow, Poland

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-177588

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[1] Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Tilly, Herve
Morschhauser, Franck
Sehn, Laurie H.
Friedberg, Jonathan W.
Trneny, M.
Sharman, Jeff P.
Herbaux, Charles
Burke, John M.
Matasar, Matthew
Rai, Shinya
Izutsu, Koji
Mehta-Shah, Neha
Oberic, Lucie
Chauchet, Adrien
Jurczak, Wojciech
Song, Yuqin
Greil, Richard
Mykhalska, Larysa
Bergua-Burgues, Juan M.
Cheung, Matthew C.
Pinto, Antonio
Shin, Ho-Jin
Hapgood, Greg
Munhoz, Eduardo
Abrisqueta, Pau
Gau, Jyh-Pyng
Hirata, Jamie
Jiang, Yanwen
Yan, Mark
Lee, Calvin
Flowers, Christopher R.
Salles, Gilles
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 351 - 363
[2] Polatuzumab Vedotin, Zanubrutinib and Rituximab Achieved Rapid and Deep Response in Previously Untreated Frail and Elderly Diffuse Large B-Cell Lymphoma Patients
Ren, Yuhong
Zhuang, Jingli
Yuan, Ling
Ji, Lili
Ke, Yang
Liu, Peng
BLOOD, 2023, 142
[3] Cost-Effectiveness of Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Matasar, Matthew
Masaquel, Anthony
Rodrigo, Ho
Launonen, Aino
Ng, Carmen
Wang, Rongrong
Fox, David
Hossain, Farah
Li, Jia
Roth, Joshua A.
Burke, John M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S359 - S360
[4] Mosunetuzumab Monotherapy Continues to Demonstrate Promising Efficacy and Durable Complete Responses in Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Olszewski, Adam J.
Avigdor, Abraham
Babu, Sunil
Levi, Itai
Eradat, Herbert
Abadi, Uri
Holmes, Houston
McKinney, Matthew
Woszczyk, Dariusz
Giannopoulos, Krzysztof
Jurczak, Wojciech
Dunshee, Diana
Yang, Annie
Zhou, Mingzhu
Qayum, Naseer
Sellam, Gila
Horowitz, Netanel A.
BLOOD, 2022, 140 : 1778 - 1780
[5] US cost-effectiveness analysis of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma
Matasar, Matthew
Masaquel, Anthony
S. Ho, Rodrigo
Launonen, Aino
Ng, Carmen D.
Wang, Rongrong
Fox, David
Hossain, Farah
Li, Jia
Burke, John M.
JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1134 - 1144
[6] An evaluation of polatuzumab vedotin for the treatment of patients with diffuse large B-cell lymphoma
Walji, Moneeza
Assouline, Sarit
EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 933 - 942
[7] EFFICACY AND SAFETY OF RITUXIMAB, BENDAMUSTINE AND DEXAMETHASONE AS INDUCTION THERAPY IN FRAIL ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA
Pezzullo, L.
Bruno, A.
Cassiodoro, G.
Bianco, R.
Villani, G.
Rosamilio, R.
Martorelli, M.
Fontana, R.
Guariglia, R.
Serio, B.
Selleri, C.
HAEMATOLOGICA, 2019, 104 : 170 - 170
[8] Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Olszewski, Adam J.
Avigdor, Abraham
Babu, Sunil
Levi, Itai
Abadi, Uri
Holmes, Houston
McKinney, Matthew
McCord, Ron
Xie, Yuying
Chen, Cindy
Sarouei, Kati
Qayum, Naseer
O'Hear, Carol
Sellam, Gila
Eradat, Herbert
BLOOD, 2020, 136
[9] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
Dietliker, N.
Kiesel, H.
Mueller, R.
Mueller, A. M.
Manz, M.
Zenz, T.
Rosler, W.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 66 - 67
[10] Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sehn, Laurie H.
Herrera, Alex F.
Flowers, Christopher R.
Kamdar, Manali K.
McMillan, Andrew
Hertzberg, Mark
Assouline, Sarit
Kim, Tae Min
Kim, Won Seog
Ozcan, Muhit
Hirata, Jamie
Penuel, Elicia
Paulson, Joseph N.
Cheng, Ji
Ku, Grace
Matasar, Matthew J.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 155 - +

← 1 2 3 4 5 →